Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

Saved in:

Bibliographic Details
Published in:	Transplantation proceedings Vol. 34; no. 7; pp. 2826 - 2827
Main Authors:	Anglicheau, D, Lautrette, A, Scieux, C, Thervet, E, Martinez, F, Flamant, M, Morinet, F, Legendre, C
Format:	Journal Article Conference Proceeding
Language:	English
Published:	New York, NY Elsevier Inc 01-11-2002 Elsevier Science
Subjects:	Acyclovir - analogs & derivatives Acyclovir - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antigens, Viral - blood Antiviral agents Antiviral Agents - therapeutic use Biological and medical sciences Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - prevention & control Dose-Response Relationship, Drug Drug Therapy, Combination Humans Immunomodulators Immunosuppression - methods Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Medical sciences Pharmacology. Drug treatments Prodrugs - therapeutic use Valacyclovir Valine - analogs & derivatives Valine - therapeutic use Valaciclovir Transplantation Homotransplantation Betaherpesvirinae Posology Kidney Human cytomegalovirus Prevention Surgery Graft Antiviral Human Opportunistic infection Herpesviridae Treatment efficiency Infection Virus Chemotherapy Immunosuppression Treatment Urinary system Decrease Viral disease Application method Immunosuppressive agent
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0041-1345 1873-2623
DOI:	10.1016/S0041-1345(02)03531-5